EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSSFOG00015004845
Gene Symbol: ERBB3
1 Cross references
279 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSSFOG00015017584
Gene Symbol: ERBB4
1 Cross references
235 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSSFOG00015023068
Gene Symbol: ERBB4
3 Cross references
235 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSSFOG00015011579
Gene Symbol: ESR1
1 Cross references
215 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSSFOG00015013629
Gene Symbol: ESR2
3 Cross references
210 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSSFOG00015018472
Gene Symbol: ESRRG
3 Cross references
266 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSSFOG00015000691
Gene Symbol: ESRRGA
1 Cross references
266 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSFOG00015001881
Gene Symbol: XPO1
3 Cross references
145 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSSFOG00015021791
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSSFOG00015000186
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSSFOG00015002778
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSSFOG00015004798
Gene Symbol: FGFR1
1 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).